Profil
Sascha Bucher is currently an Independent Non-Executive Director at Tarsier Pharma Ltd. since 2018 and Head-Global Transactions at Roivant Sciences GmbH.
Former positions include Director at Sumitomo Pharma Switzerland GmbH and Deputy Head-Global M&A at Roche Holding AG from 2009 to 2016.
Education includes an MBA from Harvard Business School.
Postes actifs de Sascha Bucher
| Sociétés | Poste | Début |
|---|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Corporate Officer/Principal | - |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Sascha Bucher
| Sociétés | Poste | Fin |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2016 |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Corporate Officer/Principal | - |
Formation de Sascha Bucher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Myovant Sciences GmbH
Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Tarsier Pharma Ltd.
Tarsier Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Health Technology |
















